Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Irritable Bowel Syndrome With Diarrhea”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableLooking for participantsNCT06681012
What this trial is testing

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl 330
Large-scale testing (Phase 3)Ended earlyNCT02239926
What this trial is testing

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Mayo Clinic 5
Testing effectiveness (Phase 2)Study completedNCT03099785
What this trial is testing

Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Cosmo Technologies Ltd 279
Post-approval studies (Phase 4)Study completedNCT00142987
What this trial is testing

Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

Who this might be right for
IBS-C and IBS With Mixed Bowel Habits
Novartis 664
Not applicableEnrolling By InvitationNCT06837064
What this trial is testing

Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome - ConstipationIrritable Bowel Syndrome - Diarrhoea+1 more
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721012
What this trial is testing

Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)

Who this might be right for
Patients With Irritable Bowel Syndrome With Diarrhea
Lei Yunshang Group 120
Large-scale testing (Phase 3)Study completedNCT01553591
What this trial is testing

Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)

Who this might be right for
Irritable Bowel Syndrome
Furiex Pharmaceuticals, Inc 1,282
Testing effectiveness (Phase 2)Study completedNCT03977155
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Boston Pharmaceuticals 133
Testing effectiveness (Phase 2)Study completedNCT03931785
What this trial is testing

MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Ironwood Pharmaceuticals, Inc. 515
Not applicableStudy completedNCT06432569
What this trial is testing

Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
University of Padova 50
Post-approval studies (Phase 4)UnknownNCT01779765
What this trial is testing

The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)

Who this might be right for
IBS
Tel-Aviv Sourasky Medical Center 130
Testing effectiveness (Phase 2)Study completedNCT03270085
What this trial is testing

Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption

Who this might be right for
Chronic DiarrheaIrritable Bowel Syndrome With DiarrheaBile Acid Malabsorption
Mayo Clinic 30
Not applicableStudy completedNCT05702255
What this trial is testing

Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Alexandria University 70
Testing effectiveness (Phase 2)Study completedNCT00399438
What this trial is testing

BMS-562086 in Patients With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Bristol-Myers Squibb 39
Not applicableStudy completedNCT01094041
What this trial is testing

Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Who this might be right for
DiarrheaDiarrhea Predominant Irritable Bowel Syndrome
Mayo Clinic 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07061184
What this trial is testing

Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

Who this might be right for
Irritable Bowel Syndrome - DiarrhoeaTraditional Chinese Medicine (TCM)N of 1 Study Design+1 more
Peking Union Medical College Hospital 50
Large-scale testing (Phase 3)Study completedNCT00189696
What this trial is testing

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc
Not applicableUnknownNCT04890405
What this trial is testing

Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.

Who this might be right for
Irritable Bowel Syndrome Variant of Childhood
Yanling Wei 70
Testing effectiveness (Phase 2)Study completedNCT01274000
What this trial is testing

Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc 409
Post-approval studies (Phase 4)Study completedNCT03729271
What this trial is testing

Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea
University of Michigan 148
Next Page